Curatio DL vs CytoReason
Curatio DL vs CytoReason, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Curatio DL is on 24/100 and CytoReason on 68/100.
Where each one leads
Curatio DL
- agent readiness: 31/100 against 21/100
- headcount growth: +17.6% against +13.7%
CytoReason
- our overall score: 68/100 against 24/100
- domain rating: 40/100 against 2/100
- headcount: 116 against 2
- LinkedIn following: 12,830 against 196
At a glance
| Measure | Curatio DL | CytoReason |
|---|---|---|
| What it is | Deep learning-powered pathology analysis for personalized cancer management and treatment. | Develops a computational model of the human body for drug discovery and development. |
| Category | Healthcare, Pathology, Cancer, HealthTech | Healthcare, Drug Discovery, Clinical Development, Biomarkers |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2017 | 2016 |
| Headquarters | Tel Aviv, Israel | Tel Aviv, Israel |
| Status | Inactive | Active |
Size, funding and growth
| Measure | Curatio DL | CytoReason |
|---|---|---|
| Employees | 2 | 116 |
| Headcount growthLast 12 months | +17.6% | +13.7% |
| Total funding | Not published | $128M |
| Latest round | Not published | Series B |
| LinkedIn followers | 196 | 12,830 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Curatio DL | CytoReason |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 24/100 | 68/100 |
| Traction | 5/100 | 60/100 |
| Team | 30/100 | 70/100 |
| Search visibility | 30/100 | 30/100 |
| Quality | Not published | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (31/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 2/100 | 40/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Curatio DL | CytoReason |
|---|---|---|
| Hosting | AWS | Not detected |
| Analytics | Not detected | Segment |
Curatio DL vs CytoReason: common questions
Which is better, Curatio DL or CytoReason?
On our 0-100 score CytoReason rates higher (68/100 against 24/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do Curatio DL and CytoReason compare on the numbers?
Curatio DL leads on agent readiness (31/100 against 21/100), headcount growth (+17.6% against +13.7%). CytoReason leads on our overall score (68/100 against 24/100), domain rating (40/100 against 2/100), headcount (116 against 2), LinkedIn following (12,830 against 196).
Read the full Curatio DL review and pricing or the CytoReason review and pricing. You can also browse other Curatio DL alternatives we track.